169 related articles for article (PubMed ID: 20427428)
1. DCIS prognostic markers: a few new candidates emerge.
Nelson NJ
J Natl Cancer Inst; 2010 May; 102(9):588-90. PubMed ID: 20427428
[No Abstract] [Full Text] [Related]
2. Can some DCIS patients avoid adjuvant therapy? Still unknown.
Schmidt C
J Natl Cancer Inst; 2011 Apr; 103(7):530-1. PubMed ID: 21436062
[No Abstract] [Full Text] [Related]
3. Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients.
Tunon-de-Lara C; André G; Macgrogan G; Dilhuydy JM; Bussières JE; Debled M; Mauriac L; Brouste V; de Mascarel I; Avril A
Ann Surg Oncol; 2011 May; 18(5):1372-9. PubMed ID: 21108045
[TBL] [Abstract][Full Text] [Related]
4. Inclusion of tumor biology molecular markers to improve the ductal carcinoma in situ ipsilateral breast tumor recurrence nomogram predictability.
Ballehaninna UK; Chamberlain RS
J Clin Oncol; 2011 Feb; 29(4):e97-8; author reply e99. PubMed ID: 21172894
[No Abstract] [Full Text] [Related]
5. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers predicting recurrence and progression of ductal carcinoma in situ treated by lumpectomy alone.
Allred DC
J Natl Cancer Inst; 2010 May; 102(9):585-7. PubMed ID: 20427432
[No Abstract] [Full Text] [Related]
7. The dilemma of DCIS.
Morrow M; O'Sullivan MJ
Breast; 2007 Dec; 16 Suppl 2():S59-62. PubMed ID: 17714949
[TBL] [Abstract][Full Text] [Related]
8. Ductal carcinoma in situ (DCIS). A highly treatable breast cancer.
Mayo Clin Womens Healthsource; 2009 Oct; 13(10):1-2. PubMed ID: 19727033
[No Abstract] [Full Text] [Related]
9. [Evaluation of predictive factors, particularly the Van Nuys index, of local recurrence in ductal carcinoma in situ of the breast: study of 166 cases with conservative treatment and review of the literature].
Denoux Y; Marnay J; Crouet H; Boute V; Delozier T; Vie B; Chasle J
Bull Cancer; 2001 Apr; 88(4):419-25. PubMed ID: 11371378
[TBL] [Abstract][Full Text] [Related]
10. Ductal carcinoma in situ: morphology-based knowledge and molecular advances.
Ross DS; Wen YH; Brogi E
Adv Anat Pathol; 2013 Jul; 20(4):205-16. PubMed ID: 23752083
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy and prognostic value of core biopsy in the management of breast cancer: a series of 542 patients.
Richter-Ehrenstein C; Müller S; Noske A; Schneider A
Int J Surg Pathol; 2009 Aug; 17(4):323-6. PubMed ID: 19029173
[TBL] [Abstract][Full Text] [Related]
12. Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?
Punglia RS; Schnitt SJ; Weeks JC
J Natl Cancer Inst; 2013 Oct; 105(20):1527-33. PubMed ID: 24068769
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
Cornfield DB; Palazzo JP; Schwartz GF; Goonewardene SA; Kovatich AJ; Chervoneva I; Hyslop T; Schwarting R
Cancer; 2004 Jun; 100(11):2317-27. PubMed ID: 15160334
[TBL] [Abstract][Full Text] [Related]
14. A pictorial journey through variants of ductal carcinoma in situ (DCIS) and DCIS mimickers.
Resetkova E
Clin Breast Cancer; 2012 Oct; 12(5):347-63. PubMed ID: 23040003
[TBL] [Abstract][Full Text] [Related]
15. Predictors of local recurrence following excision alone for ductal carcinoma in situ.
Hetelekidis S; Collins L; Silver B; Manola J; Gelman R; Cooper A; Lester S; Lyons JA; Harris JR; Schnitt SJ
Cancer; 1999 Jan; 85(2):427-31. PubMed ID: 10023711
[TBL] [Abstract][Full Text] [Related]
16. [The consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999].
Schwartz GF; Solin LJ; Olivotto IA; Ernster VL;
Bull Cancer; 2000 Jun; 87(6):499-506. PubMed ID: 10903791
[No Abstract] [Full Text] [Related]
17. [Ductal carcinoma in situ of the breast].
Procaccini E; Ruggiero R; Docimo G; Iovino F; Procaccini F; Gili S; Lo Schiavo F
G Chir; 2006; 27(1-2):40-4. PubMed ID: 16608632
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
[TBL] [Abstract][Full Text] [Related]
19. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
Westenberg AH; Rutgers EJ; Peterse JL; Hendriks JH; Beex LV; van Tienhoven G
Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2157-61. PubMed ID: 14626831
[TBL] [Abstract][Full Text] [Related]
20. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Boyages J; Delaney G; Taylor R
Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
